Cromsource, an international CRO, is delivering several modules of a training course on clinical research best practice organized by the SIFC (Italian Cystic Fibrosis Society). The course commenced in December 2014 and will complete in February 2015.

Effective development of therapies in rare diseases such as cystic fibrosis relies on the involvement of physicians working in specialized clinics. These clinicians are then able to offer participation in such research projects to patients under their care. By offering training in clinical research best practice, SIFC hopes physicians and their teams may be able to engage even more in future clinical research programs and offer participation to more patients with cystic fibrosis.

During the course, Cromsource personnel are training physicians and their teams on topics including typical aspects of a clinical research study protocol, the responsibilities of the physician and clinical staff involved in the research and the regulatory application and approval process.

Oriana Zerbini, M.D., founder and CEO of Cromsource, said, “We are delighted to take part in this initiative and work alongside representatives from the Italian ISS (National High Health Commission), the U.S. Cystic Fibrosis Foundation, ethics committees and various pharmaceutical companies.”